GlaxoSmithKline Consumer resumes operations at Nabha plant

Published On 2016-06-16 11:51 GMT   |   Update On 2016-06-16 11:51 GMT

New Delhi: GlaxoSmithKline Consumer Healthcare said it has resumed operations at its manufacturing facility at Nabha in Punjab following a wage settlement agreement with its striking workers.


The company had suspended operations temporarily at factory from May 21 following disruptions by its workforce who were demanding hike in wages.


"The operations at the said factory have now resumed with effect from June 15, 2016," GSKCH said in a regulatory filing.


When asked if the company has inked a wage settlement agreement with the workers at the plant, a company spokesperson told : "Yes, the settlement has been signed amicably with the workers and is in-line with industry standards."


GSKCH produces Horlicks and Boost at the plant. Besides, Nabha, the company also has manufacturing facilities at Rajamundry in Andhra Pradesh and Sonepat in Haryana.


It also has third party manufacturing operations at various locations.

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News